Macro Digest: Mind the coronavirus risks Macro Digest: Mind the coronavirus risks Macro Digest: Mind the coronavirus risks

Macro Digest: Mind the coronavirus risks

Macro 4 minutes to read
Steen Jakobsen

Chief Investment Officer

Summary:  The market is proving slow to recognize the risks of a dramatic downgrade to global growth this year as a consequence of the coronavirus outbreak and its effects on global supply chains and consumer activity, even as well all hope for a minimum toll on human life. Here we consider where the market will react to this situation, with special focus on the always slow to react US Federal Reserve.


Conclusion:

Independently of the severity of the coronavirus itself, the damage to global growth is now both given and highly probable, as is the ongoing disruption to global supply chains.

Reaction:

Expect significant repricing of short-term policy rates (read: the Fed) down to protect yield curve steepness. By the end of February, as much as 100 basis points lower global growth should be fully priced and companies will submit much lower guidance on this disruption (Apple started yesterday).

Biggest impacts:

  • US Fixed Income yield lower: 2,5,10,30 Y – be long the long end
  • Gold higher – Real rates will drop
  • USDJPY testing lower…
  • Volatility upside potentially on less transparency
  • EURCHF downside – manipulator status challenged by US treasury plus safe haven
  • Watch commodity collapse risks into credit space

 

Chart: CCC-rated credit spreads via BofAML
The junk bond segment has very high concentration in energy and hence acts as ‘barometer’ on credit tightness.

 

Source: St. Louis Federal Reserve FRED

The SaxoStrats view:

We believe market has been and remains too complacent on the economic cost from the virus. We remain confident this will be under control ultimately and as soon as travel restrictions create better transparency on the total number of people hit by virus. The response has been faster this time around. We are no experts on risks of the virus itself and will limit our main call to impact from economic and market side.

We do see much lower policy rates from the US and expect a full 25-bp rate cut being priced in by the end of February and likely three cuts in all by mid-summer. (This will fit our long term view that US real rates are 100 bps too high versus the rest of world as US economic cycle lags global cycle)

As always, the market doesn’t take the Fed at its word, as the Fed continue to suggest a positive outlook on the economy, as already now the market is 80% certain that two cuts will happen by the end of the year.

Source: Bloomberg

There are several factors that will drive markets over the next few weeks:

  • The coronavirus: the race to get ahead of contagion/spread as well as treatment outcomes.
  • The supply chain disruptions: we thought the US-China trade dispute was bad, but the fall out from the coronavirus in terms of delays and backups could be far worse in terms of actual on-the-ground effects.
  • Slow policy response: both the Fed and Bank of England mentioned the virus, but as usual have decided to wait rather than act.
  • Finally, do not ignore the Democratic nomination in Iowa next week: Sanders looks like a winner there and is gaining momentum elsewhere in the US as well.

Some notes from the Economist:

  • The World Bank has estimated that as much as 90% of the economic damage from epidemics stems from people’s fear of associating with others
  • Hubei province, Wuhan capital, is approximately 4.5% of China’s GDP
  • China is today four times larger economically to the rest of world than in 2003 (SARS)
  • Bloomberg rank Wuhan 13th out of 2,000 Chinese cities for its role in supply chains.
  • Chen Long of Plenum, a consultancy, thinks China growth could slouch to 2% YoY in Q1, its weakest in decades, down from 6% in Q4 2019. But he expects strong rebound when the country gets back to normal
  • China government economist> Q1 GDP may slip to 5% (Source: Purevaluematrics’s Stephan Collet)

Latest must reads from SaxoStrats:

https://www.home.saxo/content/articles/equities/coronavirus-uncertainty-not-priced-in-and-us-technology-earnings-superiority-30012020

https://www.home.saxo/content/articles/equities/industries-that-are-hit-the-hardest-by-coronavirus-29012020

https://www.home.saxo/content/articles/forex/fx-update-second-wave-of-coronavirus-fears-broadens-30012020

https://www.home.saxo/content/articles/commodities/copper-points-to-more-market-weakness-ahead-29012020

https://www.home.saxo/content/articles/macro/macro-dragon-special-s1e3-28012020

 

Steen Jakobsen

Chief Investment Officer,  Saxo Bank Group

Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-hk/about-us/awards.

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.